Pathogenetic significance of anti-lymphocyte autoantibodies in systemic lupus erythematosus
- 30 April 1992
- journal article
- review article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 63 (1) , 13-16
- https://doi.org/10.1016/0090-1229(92)90085-3
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Two types of antibodies inhibiting interleukin‐2 production by normal lymphocytes in patients with systemic lupus erythematosusArthritis & Rheumatism, 1989
- The role of interleukin 2 in autoimmunityImmunology Today, 1989
- Leukocyte cell surface enzymology: CD45 (LCA, T200) is a protein tyrosine phosphataseImmunology Today, 1989
- The Leukocyte Common Antigen FamilyAnnual Review of Immunology, 1989
- Systemic lupus erythematosus sera inhibit antigen presentation by macrophages to T cellsClinical Immunology and Immunopathology, 1988
- A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.Journal of Clinical Investigation, 1987
- Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.Journal of Clinical Investigation, 1984
- Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosusClinical Immunology and Immunopathology, 1981
- Detection of Antilymphocyte Antibody with Two-Color Method in Systemic Lupus Erythematosus and Its Heterogeneous Specificities against Human T-Cell SubsetsJournal of Clinical Investigation, 1979
- Antibodies specific for human T lymphocytes in cold agglutinin and lymphocytotoxic seraEuropean Journal of Immunology, 1973